HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma.
By Nicolas Dupin, T. Diss, P. Kellam, M. Tulliez, Ming-Qing Du, D. Sicard, R. Weiss, P. Isaacson, C. Boshoff. Blood, 2000
667 citations recorded by the source corpus.
Subfields: Oncology, Physiology
View Paper: https://www.semanticscholar.org/paper/ef693376bfe36545c74a3ef774b5ccd2d8f70abf
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
Citations in the corpus
- iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns (2012, background): “Strictly speaking, multicentric Castleman disease is not a cancer, but a rare polyclonal lymphoproliferative disease that can progress to plasmablastic lymphoma (Dupin et al., 2000).”